Venrock Healthcare Capital Partners is a venture capital fund headquartered in Palo Alto, California. It was founded in March 2009 as a subsidiary of Venrock, a venture capital office of the Rockefeller family. It makes development and late stage in private healthcare companies. It also has an office in New York.
When the healthcare specific firm was launched in 2009, its initial fund was valued at $194 million. Venrock Healthcare Capital Partners II was announced in 2014 and closed at $200 million. In 2018, the firm raised $400 million for its third fund.
A biopharmaceutical company dedicated to the development of novel therapeutics in the field of Epigenetics